BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 31158779)

  • 1. Changes in tryptophan metabolism during pregnancy and postpartum periods: Potential involvement in postpartum depressive symptoms.
    Teshigawara T; Mouri A; Kubo H; Nakamura Y; Shiino T; Okada T; Morikawa M; Nabeshima T; Ozaki N; Yamamoto Y; Saito K
    J Affect Disord; 2019 Aug; 255():168-176. PubMed ID: 31158779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway.
    Guloksuz S; Arts B; Walter S; Drukker M; Rodriguez L; Myint AM; Schwarz MJ; Ponds R; van Os J; Kenis G; Rutten BP
    Brain Behav Immun; 2015 Aug; 48():48-52. PubMed ID: 25765557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity.
    Wichers MC; Koek GH; Robaeys G; Verkerk R; Scharpé S; Maes M
    Mol Psychiatry; 2005 Jun; 10(6):538-44. PubMed ID: 15494706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kynurenine pathway changes in late-life depression.
    Wu Y; Zhong X; Mai N; Wen Y; Shang D; Hu L; Chen B; Zhang M; Ning Y
    J Affect Disord; 2018 Aug; 235():76-81. PubMed ID: 29655078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal IL-6 levels and activation of the tryptophan to kynurenine pathway are associated with depressive but not anxiety symptoms across the perinatal and the post-partum period in a low-risk sample.
    Nazzari S; Molteni M; Valtorta F; Comai S; Frigerio A
    Brain Behav Immun; 2020 Oct; 89():175-183. PubMed ID: 32531426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of tryptophan, kynurenine and neopterin in women with and without postpartum blues.
    Kohl C; Walch T; Huber R; Kemmler G; Neurauter G; Fuchs D; Sölder E; Schröcksnadel H; Sperner-Unterweger B
    J Affect Disord; 2005 Jun; 86(2-3):135-42. PubMed ID: 15935232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder.
    Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Ning Y
    Psychoneuroendocrinology; 2019 Mar; 101():72-79. PubMed ID: 30419374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tryptophan, kynurenine, and kynurenine metabolites: Relationship to lifetime aggression and inflammatory markers in human subjects.
    Coccaro EF; Lee R; Fanning JR; Fuchs D; Goiny M; Erhardt S; Christensen K; Brundin L; Coussons-Read M
    Psychoneuroendocrinology; 2016 Sep; 71():189-96. PubMed ID: 27318828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Metabolic Profiles of the Tryptophan-Kynurenine Pathway in the high risk subjects of major depressive disorder.
    Sakurai M; Yamamoto Y; Kanayama N; Hasegawa M; Mouri A; Takemura M; Matsunami H; Miyauchi T; Tokura T; Kimura H; Ito M; Umemura E; Boku AS; Nagashima W; Tonoike T; Kurita K; Ozaki N; Nabeshima T; Saito K
    Sci Rep; 2020 Feb; 10(1):1961. PubMed ID: 32029791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tryptophan pathway alterations in the postpartum period and in acute postpartum psychosis and depression.
    Veen C; Myint AM; Burgerhout KM; Schwarz MJ; Schütze G; Kushner SA; Hoogendijk WJ; Drexhage HA; Bergink V
    J Affect Disord; 2016 Jan; 189():298-305. PubMed ID: 26454336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms?
    Quak J; Doornbos B; Roest AM; Duivis HE; Vogelzangs N; Nolen WA; Penninx BW; Kema IP; de Jonge P
    Psychoneuroendocrinology; 2014 Jul; 45():202-10. PubMed ID: 24845191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma tryptophan and kynurenine pathway metabolites in abstinent patients with alcohol use disorder and high prevalence of psychiatric comorbidity.
    Vidal R; García-Marchena N; O'Shea E; Requena-Ocaña N; Flores-López M; Araos P; Serrano A; Suárez J; Rubio G; Rodríguez de Fonseca F; Colado MI; Pavón FJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Aug; 102():109958. PubMed ID: 32360814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant effect of repeated ketamine administration on kynurenine pathway metabolites in patients with unipolar and bipolar depression.
    Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Li M; Ning Y
    Brain Behav Immun; 2018 Nov; 74():205-212. PubMed ID: 30213652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early activation of the kynurenine pathway predicts early death and long-term outcome in patients resuscitated from out-of-hospital cardiac arrest.
    Ristagno G; Latini R; Vaahersalo J; Masson S; Kurola J; Varpula T; Lucchetti J; Fracasso C; Guiso G; Montanelli A; Barlera S; Gobbi M; Tiainen M; Pettilä V; Skrifvars MB;
    J Am Heart Assoc; 2014 Aug; 3(4):. PubMed ID: 25092787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation between kynurenine metabolites and postpartum depression].
    Wang S; Quan C; Tan Y; Wen S; Zhang J; Duan K
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 43(7):725-731. PubMed ID: 30124207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the tryptophan-kynurenine axis in association to therapeutic response in clinically depressed patients undergoing psychiatric rehabilitation.
    Reininghaus B; Riedrich K; Dalkner N; Bengesser SA; Birner A; Platzer M; Hamm C; Gostner JM; Fuchs D; Reininghaus EZ
    Psychoneuroendocrinology; 2018 Aug; 94():25-30. PubMed ID: 29753175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous determination of tryptophan, kynurenine, kynurenic acid, xanthurenic acid and 5-hydroxytryptamine in human plasma by LC-MS/MS and its application to acute myocardial infarction monitoring.
    Tong Q; Song J; Yang G; Fan L; Xiong W; Fang J
    Biomed Chromatogr; 2018 Apr; 32(4):. PubMed ID: 29193181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between the tryptophan-kynurenine pathway and painful physical symptoms in patients with major depressive disorder.
    Yun Y; Zhang Q; Zhao W; Ma T; Fan H; Bai L; Ma B; Qi S; Wang Z; An H; Yang F
    J Psychosom Res; 2022 Dec; 163():111069. PubMed ID: 36335711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kynurenine pathway changes in late-life depression with memory deficit.
    Wu Y; Mai N; Zhong X; Wen Y; Zhou Y; Li H; Shang D; Hu L; Chen X; Chen B; Zhang M; Ning Y
    Psychiatry Res; 2018 Nov; 269():45-49. PubMed ID: 30145300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression.
    Raison CL; Dantzer R; Kelley KW; Lawson MA; Woolwine BJ; Vogt G; Spivey JR; Saito K; Miller AH
    Mol Psychiatry; 2010 Apr; 15(4):393-403. PubMed ID: 19918244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.